Xarelto fda approval date?

When did the FDA approve Xarelto (rivaroxaban)?

Xarelto (rivaroxaban) was approved by the U.S. FDA on July 1, 2011. [1]

What was Xarelto approved for at launch?

At approval, Xarelto was indicated for reducing the risk of stroke and systemic embolism in nonvalvular atrial fibrillation, along with other initial indications listed at launch in the FDA approval materials. [1]

Source

[1] https://www.drugpatentwatch.com/p/xarelto